Cornea damage

Stem cells from the health part of the eye (limbal stem cells) are being investigated as possible treatments for damage to the cornea. Click on the link provided to find out more about each trial. It remains too early to know which approach will be most suitable. We need evidence collected in clinical trials to determine if a proposed stem cell treatment is both safe and effective.

tagged as Cornea damage

  • Epithelial Cell Transfer for Severe Corneal Disease Location: Australia
    Overview: This trial aims to evaluate a new contact lens system to culture and transfer limbal stem cells to the corneal surface in patients with limbal stem cell deficiency. The trial is being conducted by the the School of Medical Sciences at the University of New South Wales. Limbal stem cells will be harvested from the patient unaffected eye and will then be cultured on specially designed contact lens, before being transferred to the patient's cornea. Participants will be monitored for complications and assessed for changes in their clinical condition, including examination of ocular health and corneal epithelium integrity. The trial started in May 2007 and expects to recruit 30 patients with limbal stem cell deficiency.
    Link to Clinical Registry
    Trial Design: Safety and Efficacy Study
    Status: Open - Recruiting
    Stem Cell: Stem Cells (unspecified)